Drug Delivery – Evaluating Off-The-Shelf and Novel Drug Delivery Solutions

During this session, Brandon Bogdalek will interview three (3)  panelists from  in the drug delivery and pharmaceutical industry. The panelists will discuss important factors to consider when evaluating off-the-shelf (OTS) drug delivery platform vs. developing a novel solution. Key topics will include cost and pricing impacts, timeline to commercialization, as well as R&D, human factors, and user needs considerations. Panelists will share their perspectives with respect to choosing OTS solutions or building a novel drug delivery platform. 

Key Takeaways

    • Important tradeoffs when considering an OTS drug delivery platform vs. novel development.
    • Best practices for novel drug delivery design and development
    • Important R&D considerations including timeline to commercialization, human factors, user needs, and more

Panelists

Register here! 

Tuesday, July 11, 2023 @ 1-2pm EDT (10-11am PDT / 12-1pm CDT)

 

Best Practices for Bringing Novel Point-of-Care Diagnostic Solutions to Market

During this session, Brandon Bogdalek will interview three (3) panelists in the diagnostics industry. The panelists will discuss best practices for...

Read More

The Innovation Imperative for Growth Stage Medical Technology Companies

During this session, Brandon Bogdalek will interview panelists from the medical technology space. The panelists will discuss the innate need to...

Read More